A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1
- 1 April 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 61 (7), 1029-1037
- https://doi.org/10.1097/00007890-199604150-00008
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilImmunological Reviews, 1993
- THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENSTransplantation, 1993
- International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathologyKidney International, 1993
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTSTransplantation, 1992
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988